KU-0058948

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameKU-0058948

Drug Alias NameKU-0058948

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitorsPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN inhibitors

TargetsPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTENPoly (ADP-Ribose) polymerase

Therapy Area/IndicationsEndometrial Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesThe Institute Of Cancer Research, London

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesThe Institute Of Cancer Research, London

Active IndicationsN/A

Inactive IndicationsEndometrial Neoplasms

Other Information

ATC CodeN/A